3 Key Takeaways
Plain English Summary- 01Core Finding
Thymic output was measured by circulating CD4+ recent thymic emigrants (RTEs) with flow cytometry, and T-cell receptor excision circles in sorted naïve CD4+ and tumor-fighting immune cells (CD8+ T cells).
- 02Study Evidence
Tested in a observational cohort study at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
What This Means for You
Hypercholesterolaemia was associated with reduced thymic output, while statin-treated patients showed partially preserved circulating CD4+ RTE levels, supporting integrated metabolic and immunologic strategies for FH management.
The Discovery
Lifelong exposure to elevated low-density lipoprotein cholesterol in familial hypercholesterolaemia (FH) patients not only increases the risk of atherosclerotic cardiovascular disease, but also affects other organs beyond the cardiovascular system. In a large FH cohort, this study investigated the effects of hypercholesterolaemia on the thymic output and explored whether lipid-lowering therapy can reverse these effects. According to the Dutch Lipid Clinic Network criteria, 562 heterozygous FH patients (236 treatment-naïve, 326 on lipid-lowering therapy) and 295 age-matched healthy controls (HCs) were enrolled. Thymic output was measured by circulating CD4+ recent thymic emigrants (RTEs) with flow cytometry, and T-cell receptor excision circles in sorted naïve CD4+ and tumor-fighting immune cells (CD8+ T cells). Repertoire diversity and clonal expansion were evaluated by T-cell receptor beta sequencing. Compared with HCs, treatment-naïve FH patients displayed a significantly reduced percentage of CD4+ RTE among naïve CD4+ T cells, particularly in those aged 18-30 years or carrying highly pathogenic LDLR variants. T-cell receptor excision circle analysis supported reduced thymic output in both CD4+ and CD8+ naïve T cells. Quantified thymic ageing further showed that FH patients reached the median CD4+ RTE percentage of HCs ∼6 years earlier (males: 19.12 vs 25.51 years; females: 19.18 vs 25.58 years). Consistent with reduced thymic output, FH patients showed skewing towards high-frequency T-cell receptor beta clones. Statin-treated FH patients, particularly females, showed higher circulating CD4+ RTE levels than statin-naïve FH patients.
How It Works, Simply
This cardiology research focuses on LDL cholesterol · T cells · Immune response. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
Thymic output was measured by circulating CD4+ recent thymic emigrants (RTEs) with flow cytometry, and T-cell receptor excision circles in sorted naïve CD4+ and CD8+ T cells.
- 02Study Evidence
Tested in a observational cohort study at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
Biological Mechanism & Study Design
Study Design & Cohort
Observational cohort study
Observational cohort study · Real-World Cohort
Biological Pathway & Modality
LDL cholesterol · T cells · Immune response
Intervention: Familial hypercholesterolaemia and thymic ageing in a Chinese cohort
Experimental Findings & Endpoints
Lifelong exposure to elevated low-density lipoprotein cholesterol in familial hypercholesterolaemia (FH) patients not only increases the risk of atherosclerotic cardiovascular disease, but also affects other organs beyond the cardiovascular system.
In a large FH cohort, this study investigated the effects of hypercholesterolaemia on the thymic output and explored whether lipid-lowering therapy can reverse these effects. According to the Dutch Lipid Clinic Network criteria, 562 heterozygous FH patients (236 treatment-naïve, 326 on lipid-lowering therapy) and 295 age-matched healthy controls (HCs) were enrolled.
Thymic output was measured by circulating CD4+ recent thymic emigrants (RTEs) with flow cytometry, and T-cell receptor excision circles in sorted naïve CD4+ and CD8+ T cells. Repertoire diversity and clonal expansion were evaluated by T-cell receptor beta sequencing.
Compared with HCs, treatment-naïve FH patients displayed a significantly reduced percentage of CD4+ RTE among naïve CD4+ T cells, particularly in those aged 18-30 years or carrying highly pathogenic LDLR variants. T-cell receptor excision circle analysis supported reduced thymic output in both CD4+ and CD8+ naïve T cells.
Quantified thymic ageing further showed that FH patients reached the median CD4+ RTE percentage of HCs ∼6 years earlier (males: 19.12 vs 25.51 years; females: 19.18 vs 25.58 years). Consistent with reduced thymic output, FH patients showed skewing towards high-frequency T-cell receptor beta clones.
Statin-treated FH patients, particularly females, showed higher circulating CD4+ RTE levels than statin-naïve FH patients.
Clinical Translation & Practice Context
Hypercholesterolaemia was associated with reduced thymic output, while statin-treated patients showed partially preserved circulating CD4+ RTE levels, supporting integrated metabolic and immunologic strategies for FH management.
The Bottom Line · Clinical Pearl
“Hypercholesterolaemia was associated with reduced thymic output, while statin-treated patients showed partially preserved circulating CD4+ RTE levels, supporting integrated metabolic and immunologic strategies for FH management.”
Published in European Heart Journal · Current Stage: Real-World Cohort
